Yahoo Finance

Overview: Tissue Regenix Group plc is a medical technology company that develops and commercializes platform technologies for bone graft substitutes and soft tissue in the United States and internationally, with a market cap of £42.03 million.

Operations: The company's revenue is derived from three segments: Dcell ($7.24 million), GBM-V ($3.28 million), and Biorinse ($21.28 million).

Market Cap: £42.03M

Tissue Regenix Group plc, with a market cap of £42.03 million, has shown resilience in the penny stock arena despite being unprofitable. Its revenue streams from Dcell, GBM-V, and Biorinse contributed to a total group revenue increase of 8% to $28.4 million for 2024. The company has managed to reduce net losses significantly over the past year and maintains a satisfactory net debt to equity ratio of 23.1%. Short-term assets exceed both short- and long-term liabilities, providing financial stability while it continues its growth trajectory with projected earnings growth of 170.82% annually according to analyst estimates.

• Take a closer look at Tissue Regenix Group's potential here in our financial health report.

• Understand Tissue Regenix Group's earnings outlook by examining our growth report.

Various Eateries

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Various Eateries PLC, along with its subsidiaries, owns, develops, and operates restaurant and hotel sites in the United Kingdom with a market capitalization of £27.57 million.

Operations: The company generates revenue primarily from its Restaurant Segment, which accounts for £45.16 million, and its Hotel Segment, contributing £4.30 million.

Market Cap: £27.57M

Various Eateries PLC, with a market cap of £27.57 million, operates in the UK restaurant and hotel sectors. Despite being unprofitable, it has improved its financial position by reducing net losses from £6.68 million to £3.36 million over the past year, while revenues increased to £49.49 million. However, concerns remain as auditors have expressed doubts about its ability to continue as a going concern due to liabilities exceeding assets and negative return on equity (-11.38%). Recent leadership changes include appointing Mark Loughborough as CEO, who brings extensive hospitality industry experience but also has past company liquidations in his history.

• Jump into the full analysis health report here for a deeper understanding of Various Eateries.

• Assess Various Eateries' future earnings estimates with our detailed growth reports.

Where To Now?

• Discover the full array of 446 UK Penny Stocks right here.

• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.

• Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Jump on the AI train with fast growing tech companies forging a new era of innovation.

• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include AIM:SEA AIM:TRX and AIM:VARE.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com